Are Peptides Making a Comeback? RFK Jr. Pushes FDA Review

Are Peptides Making a Comeback? RFK Jr. Pushes FDA Review – 15 April 2026

April 15, 2026 – Just days after a landmark regulatory update, the peptide world is buzzing with a single question: Are peptides finally making a comeback?

If you’ve been following the space, you already know something big happened. On April 15th, new documents surfaced confirming that 12 peptides are set to be removed from the FDA’s “Category 2 – Do Not Compound” list within 7 days. And leading the charge? None other than HHS Secretary Robert F. Kennedy Jr, who has publicly backed the reversal, calls the original restrictions "scientifically unfounded".

The news has drawn praise from figures like Donald Trump Jr. and ignited a firestorm of discussion inside every major biohacking forum.

The 12 Peptides Headed for Review

According to the official update, the following compounds are now under active review for removal from the high-risk list:

BPC-157 – tissue repair, gut healing
TB-500 – regeneration, recovery
Semaglutide – GLP-1 metabolic research
Retatrutide – triple-agonist metabolic studies
MOTS-c – mitochondrial aging research
Epithalon – telomere longevity
GHK-Cu – copper peptide for connective tissue
Thymosin Alpha-1 – immune modulation
PT-141 – melanocortin research
Selank – anxiolytic cognitive research
Semax – neuroplasticity
CJC-1295 – growth hormone secretagogue

This is not fully legalised, but it is the single biggest regulatory shift in the peptide space in over a decade.

Why This Is a Comeback

For years, the peptide market has been split into two worlds:

The underground research market – easy access, low cost, but no universal sterility testing, no endotoxin screening, and inconsistent quality.
Compounding pharmacies – doctor oversight and verified quality—are legally restricted from preparing most of these peptides.

The FDA's recent action fills this void. Compounding pharmacies will soon be able to legally prepare these 12 peptides, bringing verified dosing, third-party testing, and medical supervision back into the equation.

Inside the Biohacking & Longevity Group on Skool , members are already calling this “the beginning of the peptide golden age". One moderator wrote: “This is what happens when science wins over politics. RFK Jr. actually listened to the researchers.”

What This Means for Researchers Right Now

Researchers and biohackers still require reliable, high-purity compounds for their work, even as the regulatory processes progress. The gold standard remains Orion Peptides , a trusted supplier of 99%+ pure, lab-tested research peptides.

Whether you’re studying BPC-157 for intestinal repair, retatrutide for metabolic pathways, or epithalon for cellular longevity, Orion Peptides delivers the following:

Third-party verified purity (99%+)
Same-day shipping on orders before 3 PM PST
Free shipping on orders over $200

And for a limited time, you can save with the Orion 10 coupon code at checkout.

The Bottom Line

Peptides are not just making a comeback—they are entering a new era of legitimacy. With RFK Jr. pushing the FDA to reverse course, and public figures like Trump Jr. amplifying the message, the industry is poised for explosive growth.

But remember: increased regulation means higher standards. The days of “buyer beware” are numbered. Now more than ever, sourcing from verified, third-party-tested suppliers like Orion Peptides is the only way to ensure your research rests on a solid foundation.

👉 Join the discussion: Biohacking & Longevity Group

👉 Get research-grade peptides: Orion Peptides – use code ORION10

Disclaimer: All products sold by Orion Peptides are for laboratory and research use only. Not for human consumption.

0 comments